Discovery of sulfonamide–pyrazole γ-secretase inhibitors
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (7) , 2148-2150
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Design, synthesis, and structure–activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline γ-secretase inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Disease-Modifying Approach to the Treatment of Alzheimerʼs DiseaseDrugs & Aging, 2009
- Recent developments in Alzheimer's disease therapeuticsBMC Medicine, 2009
- Identification of γ-Secretase Inhibitor Potency Determinants on PresenilinJournal of Biological Chemistry, 2008
- Substituted 2-oxo-azepane derivatives are potent, orally active γ-secretase inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivativesBioorganic & Medicinal Chemistry Letters, 2008
- Amino-caprolactam derivatives as γ-secretase inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Syntheses of Potent, Selective, and Orally Bioavailable Indazole-Pyridine Series of Protein Kinase B/Akt Inhibitors with Reduced HypotensionJournal of Medicinal Chemistry, 2007
- Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK InhibitorsJournal of Medicinal Chemistry, 2007
- Alzheimer's diseaseThe Lancet, 2006